Home›Botulinum Toxin Type A›Botulinum Toxin Type A + Rimabotulinumtoxinb

Does Botulinum Toxin Type A Interact with Rimabotulinumtoxinb?

Botulinum Toxin Type A and Rimabotulinumtoxinb have a major drug interaction according to U.S. FDA drug labeling data. Concurrent or overlapping administration (within 4 months) may exacerbate excessive neuromuscular weakness and paralysis. The mechanism involves potentiation of neuromuscular paralysis. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Botulinum Toxin Type A Class
Acetylcholine Release Inhibitor
Rimabotulinumtoxinb Class
Acetylcholine Release Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Botulinum Toxin Type A and Rimabotulinumtoxinb occurs because potentiation of neuromuscular paralysis. Clinically, this means concurrent or overlapping administration (within 4 months) may exacerbate excessive neuromuscular weakness and paralysis. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Botulinum Toxin Type A and your doctor is considering prescribing Rimabotulinumtoxinb (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Botulinum Toxin Type A(Dysport)+💊 Rimabotulinumtoxinb(Myobloc)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Acetylcholine Release Inhibitor
Drug B class
Acetylcholine Release Inhibitor
Source
NLP:rimabotulinumtoxinb

What this means in plain English

Concurrent or overlapping administration (within 4 months) may exacerbate excessive neuromuscular weakness and paralysis.

What the FDA label says

"Potentiation of neuromuscular paralysis"

📖 Source: NLP:rimabotulinumtoxinb

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Botulinum Toxin Type A and Rimabotulinumtoxinb against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.